Manzano GS[au] - Search Results

Year	Number of Results
2018	1
2020	4
2021	5
2022	5
2023	0

1

Update on neuromyelitis optica spectrum disorder.

Holroyd KB, Manzano GS, Levy M. Holroyd KB, et al. Among authors: manzano gs. Curr Opin Ophthalmol. 2020 Nov;31(6):462-468. doi: 10.1097/ICU.0000000000000703. Curr Opin Ophthalmol. 2020. PMID: 33009077 Free PMC article. Review.

2

Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19: Systematic Review and Meta-synthesis.

Manzano GS, McEntire CRS, Martinez-Lage M, Mateen FJ, Hutto SK. Manzano GS, et al. Neurol Neuroimmunol Neuroinflamm. 2021 Aug 27;8(6):e1080. doi: 10.1212/NXI.0000000000001080. Print 2021 Nov. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34452974 Free PMC article.

3

A Seizure After COVID-19 Vaccination in a Patient on Clozapine.

Makhlouf AT, Van Alphen MU, Manzano GS, Freudenreich O. Makhlouf AT, et al. Among authors: manzano gs. J Clin Psychopharmacol. 2021 Nov-Dec 01;41(6):689-690. doi: 10.1097/JCP.0000000000001488. J Clin Psychopharmacol. 2021. PMID: 34735102 No abstract available.

4

A multi-center case series of sarcoid optic neuropathy.

Webb LM, Chen JJ, Aksamit AJ, Bhattacharyya S, Chwalisz BK, Balaban D, Manzano GS, Ali AS, Lord J, Clardy SL, Samudralwar RD, Mao-Draayer Y, Garrity JA, Bhatti MT, Turner LE, Flanagan EP. Webb LM, et al. Among authors: manzano gs. J Neurol Sci. 2021 Jan 15;420:117282. doi: 10.1016/j.jns.2020.117282. Epub 2020 Dec 19. J Neurol Sci. 2021. PMID: 33358503

5

Covid-19-Associated Myopathy Caused by Type I Interferonopathy.

Manzano GS, Woods JK, Amato AA. Manzano GS, et al. N Engl J Med. 2020 Dec 10;383(24):2389-2390. doi: 10.1056/NEJMc2031085. Epub 2020 Nov 20. N Engl J Med. 2020. PMID: 33216474 Free PMC article. No abstract available.

6

Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis: An observational study.

Manzano GS, Rice DR, Klawiter EC, Matiello M, Gillani RL, Tauhid SS, Bakshi R, Mateen FJ. Manzano GS, et al. Mult Scler. 2022 Jun;28(7):1146-1150. doi: 10.1177/13524585221092309. Epub 2022 Apr 27. Mult Scler. 2022. PMID: 35475382

7

COVID-19 and the risk of CNS demyelinating diseases: A systematic review.

Lotan I, Nishiyama S, Manzano GS, Lydston M, Levy M. Lotan I, et al. Among authors: manzano gs. Front Neurol. 2022 Sep 20;13:970383. doi: 10.3389/fneur.2022.970383. eCollection 2022. Front Neurol. 2022. PMID: 36203986 Free PMC article.

8

Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD Within a Real-World Cohort.

Manzano GS, Salky R, Mateen FJ, Klawiter EC, Chitnis T, Levy M, Matiello M. Manzano GS, et al. Front Neurol. 2022 Jun 20;13:947630. doi: 10.3389/fneur.2022.947630. eCollection 2022. Front Neurol. 2022. PMID: 35795797 Free PMC article.

9

Disease modifying therapy management of multiple sclerosis after stem cell therapies: A retrospective case series.

Manzano GS, Holroyd KB, Kaplan T, Bhattacharyya S, Chitnis T, Hotan G, Zurawski J, Galetta KM, Mateen FJ. Manzano GS, et al. Mult Scler Relat Disord. 2022 Jul;63:103861. doi: 10.1016/j.msard.2022.103861. Epub 2022 May 10. Mult Scler Relat Disord. 2022. PMID: 35576727

10

Case Report of Spinal Cord Involvement in Susac Syndrome Masquerading as a Multiple Sclerosis Mimic.

Song KW, Manzano GS, Kharal GA, Venna N. Song KW, et al. Among authors: manzano gs. Neurohospitalist. 2022 Jul;12(3):556-558. doi: 10.1177/19418744221097473. Epub 2022 Apr 25. Neurohospitalist. 2022. PMID: 35755220

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results